Quinolinate phosphoribosyltransferase is an antiviral host factor against hepatitis c virus infection | |
Wang, Zhilong1,2,5,9; Gao, Yanhang3,8; Zhang, Chao5; Hu, Haiming1,2; Guo, Dongwei7; Xu, Yi4; Xu, Qiuping1,2,6; Zhang, Weihong1,2; Deng, Sisi1,2; Lv, Pingyun1,2 | |
刊名 | Scientific reports |
2017-07-19 | |
卷号 | 7页码:10 |
ISSN号 | 2045-2322 |
DOI | 10.1038/s41598-017-06254-4 |
通讯作者 | Tang, hong(htang@ips.ac.cn) |
英文摘要 | Hcv infection can decrease nad(+)/nadh ratio, which could convert lipid metabolism to favor hcv replication. in hepatocytes, quinolinate phosphoribosyl transferase (qprt) catabolizes quinolinic acid (qa) to nicotinic acid mononucleotide (namn) for de novo nad synthesis. however, whether and how hcv modulates qprt hence the lipogenesis is unknown. in this work, we found qprt was reduced significantly in livers of patients or humanized c/o-tg mice with persistent hcv infection. mechanistic studies indicated that hcv ns3/4a promoted proteasomal degradation of qprt through smurf2, an e3 ubiquitin-protein ligase, in huh7.5.1 cells. furthermore, qprt enzymatic activity involved in suppression of hcv replication in cells. activation of qprt with clofibrate (clo) or addition of qprt catabolite nad both inhibited hcv replication in cells, probably through nad(+)-dependent sirt1 inhibition of cellular lipogenesis. more importantly, administration of clo, a hypolipidemic drug used in clinics, could significantly reduce the viral load in hcv infected c/o-tg mice. take together, these results suggested that hcv infection triggered proteasomal degradation of qprt and consequently reduced de novo nad synthesis and lipogenesis, in favor of hcv replication. hepatic qprt thus likely served as a cellular factor that dampened productive hcv replication. |
WOS关键词 | METABOLISM DISORDERS ; LIPID-METABOLISM ; RIG-I ; PROTEIN ; UBIQUITINATION ; REPLICATION ; SYSTEMS ; MICE ; POLY(ADP-RIBOSE) ; DEGRADATION |
WOS研究方向 | Science & Technology - Other Topics |
WOS类目 | Multidisciplinary Sciences |
语种 | 英语 |
出版者 | NATURE PUBLISHING GROUP |
WOS记录号 | WOS:000405895000028 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2373410 |
专题 | 武汉病毒研究所 |
通讯作者 | Tang, Hong |
作者单位 | 1.Chinese Acad Sci, Wuhan Inst Virol, Joint Lab Translat Precis Med, Wuhan 430071, Hubei, Peoples R China 2.Chinese Acad Sci, Guangzhou Women & Children` s Med Ctr, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China 3.Chinese Acad Sci, Wuhan Inst Virol, Joint Lab Translat Precis Med, Guangzhou 510623, Guangdong, Peoples R China 4.Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China 5.Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China 6.Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China 7.Chinese Acad Agr Sci, Harbin Vet Res Inst, Harbin 150001, Heilongjiang, Peoples R China 8.Jilin Univ, Dept Hepatol, Hosp 1, Changchun 130021, Jilin, Peoples R China 9.Univ Chinese Acad Sci, Beijing 10049, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Zhilong,Gao, Yanhang,Zhang, Chao,et al. Quinolinate phosphoribosyltransferase is an antiviral host factor against hepatitis c virus infection[J]. Scientific reports,2017,7:10. |
APA | Wang, Zhilong.,Gao, Yanhang.,Zhang, Chao.,Hu, Haiming.,Guo, Dongwei.,...&Tang, Hong.(2017).Quinolinate phosphoribosyltransferase is an antiviral host factor against hepatitis c virus infection.Scientific reports,7,10. |
MLA | Wang, Zhilong,et al."Quinolinate phosphoribosyltransferase is an antiviral host factor against hepatitis c virus infection".Scientific reports 7(2017):10. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论